Major shareholder purchases 4,000,000 shares of $ERNA
A recent insider purchase made by Charles Cherington, a 10% owner of the company with the ticker symbol $ERNA, involved acquiring 4,000,000 shares for an estimated $2,000,000 on February 10, 2026. This trade was disclosed through data extracted from a recent SEC filing by Quiver Quantitative. This acquisition significantly raised Cherington’s stake in this class of stock by approximately 143.9%, bringing his total holdings to 6,779,440 shares of this particular $ERNA stock.
In the past six months, insider trading activity within $ERNA has occurred only once, with Cherington’s purchase being the sole transaction. There have been no reported sales during this period. This reveals Cherington’s increased confidence in the company’s growth potential and financial performance, as evidenced by his substantial purchase of 4,000,000 shares.
Looking at hedge fund activities related to $ERNA, eight institutional investors have augmented their positions in the stock, while three have reduced their stakes in the most recent quarter. Notable movements include Corient Private Wealth LLC adding 420,569 shares (+2400.1%) to their portfolio in Q3 2025, Susquehanna International Group, LLP removing 30,854 shares from their holdings in Q4 2025, and Vanguard Group Inc adding 24,775 shares (+222.3%) in the same quarter. Other hedge funds such as HRT Financial LP, Tower Research Capital LLC, Geode Capital Management, LLC, and Fortitude Family Office, LLC have also made significant adjustments to their $ERNA stock portfolios.
These changes in institutional holdings and insider transactions indicate varying levels of confidence and belief in the future performance of $ERNA as a company. Investors are closely monitoring these activities to gauge the sentiment and outlook regarding the stock’s potential growth and value in the market.
It is important to note that this article does not serve as financial advice, and individuals should conduct their own research and due diligence before making any investment decisions. For more information, readers are advised to refer to Quiver Quantitative’s disclaimers for additional details.